Sign Out
Ursoliv: Dissolution of gallstones in patients with radiolucent, noncalcified, gallbladder stones less than 20 mm diameter in whom elective cholecystectomy would be undertaken except for the presence of increased surgical risk due to systemic disease, advanced age, idiosyncratic reaction to general anesthesia, or for patients who refuse surgery.
Prevention of gallstone formation in obese patients experiencing rapid weight loss.
Compensated primary biliary cirrhosis.
Chronic cholestatic syndrome with various liver lesions.
Ursoliv 500: For the dissolution of cholesterol-rich gallstones in the bladder and for the treatment of biliary reflux gastritis and cholestatic liver disease.
For the symptomatic treatment of primary biliary cirrhosis (PBC), in patients without decompensated hepatic cirrhosis.
Continue with Google